In addition, it is known that GLP-1 affects gastric emptying and inhibits pancreatic -cells apoptosis
SUMMIT included 731 patients with HFpEF and obesity with NYHA Class II symptoms, and evaluated the dual GLP-1/GIP receptor agonist tirzepatide
Im not going to tell you what to do about that gap between optimal therapy and available therapy, but I will tell you to make informed decisions with your eyes wide open about what the actual clinical data shows
It is inactive, which means it must undergo a conversion process in the body before it can be absorbed and used
The grim reality when you stop GLP1s cold turkey GLP1s help you lose weight because they curb appetite, so when you stop suddenly, hunger and calorie intake skyrocket The result
This may include a combination of therapies, lifestyle modifications, and nutritional support